Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 168   

Articles published

GSK 1,453.47 -3.53 (-0.24%)
price chart
Why I'd buy this biotechnology star alongside GlaxoSmithKline plc
There's still a youthful growth-investor hidden within me, and I do get tempted by potential future stars from time to time. Right now, I'm looking at the prospects for MaxCyte (LSE: MXCT), which released first-half results Tuesday.
GlaxoSmithKline plc (GSK): Time For A Financial Health Check
A market capitalization of $95.56B puts GlaxoSmithKline plc (NYSE:GSK) in the basket of stocks categorized as large-caps. These stocks draw significant attention from the investing community due to its size and liquidity.
GlaxoSmithKline plc 17.6% Potential Upside Indicated by Bryan Garnier  DirectorsTalk Interviews
Insider Buying: GlaxoSmithKline plc (LON:GSK) Insider Acquires 8 Shares of Stock  The Ledger Gazette
FDA OKs Glaxo's inhaler, first one to combine 3 medicines
This photo provided by GlaxoSmithKline PLC shows the company's Trelegy Ellipta inhaler. Late Monday, Sept. 18, 2017, the Food and Drug Administration approved the product, which is the first inhaler that combines three medicines to ease breathing in ...
Innoviva (INVA) & GlaxoSmithKline Plc (GSK) Granted Approval by FDA for ...  StreetInsider.com
GlaxoSmithKline gets 'positive opinion' from EMA panel for three-in-one ...
GlaxoSmithKline plc (LON:GSK) has announced that a European Medicines Agency (EMA) panel has recommended a three-in-one inhaled drug developed with US firm Innoviva, Inc.(NASDAQ: INVA) as a treatment for severe chronic obstructive pulmonary ...
One long-term growth stock I'd buy alongside GlaxoSmithKline plc
It is fair to say that GlaxoSmithKline (LSE: GSK) is not the flavour of the month right now - its share price has rattled 14% lower from the 2017 peak of �17.22 per share struck in June.
GlaxoSmithKline plc (GSK) Receives GBX 1722.70 Consensus Target Price from ...  The Ledger Gazette
BidaskClub Upgrades GlaxoSmithKline PLC (GSK) to “Sell”  Dispatch Tribunal
Does GlaxoSmithKline plc offer more investment potential than AstraZeneca plc ...
In the last month, the GlaxoSmithKline share price has fallen 2.5%. That's a disappointing result in my view, and is behind the performance of some of its healthcare sector peers such as AstraZeneca plc (LON:AZN) (AZN.L), Shire PLC (LON:SHP) (SHP.L ...
This four-bagger should continue to thrash GlaxoSmithKline plc
Advanced Medical Solutions Group (LSE: AMS) has an exciting growth story to tell with its share price up 305% in the last five years.
GSK asthma study results published in medical journal and presented at ...
GlaxoSmithKline plc (LON:GSK) said the positive results from its study of asthma treatment, Relvar Eillipta, has been published in The Lancet medical journal and presented at the European Respiratory Society International Congress in Milan.
Buy the stocks that will change your money multiplying rate: GlaxoSmithKline ...
GlaxoSmithKline plc(NYSE:GSK) Healthcare Drug Manufacturers - Major has a current market price of 40.05 with a change in price of -0.47%.
Why I've sold this turnaround stock to buy GlaxoSmithKline plc
It has recovered to a large extent during the course of 2017, but now could face a highly uncertain future while lacking a sufficiently wide margin of safety.